Why CMIC CRO
Why Global Biopharma Choose CMIC as Their CRO in Japan

Since becoming Japan’s first CRO in 1992, CMIC CRO has supported pharmaceutical development in Japan for over 30 years. Combining deep local expertise with extensive experience working alongside global CROs and biotech companies, we serve as a strategic bridge between Japan’s development environment and global development strategies.

Through strong strategic consulting capabilities, proven execution as an ICCC, broad therapeutic expertise, and close collaboration across the CMIC Group, CMIC CRO delivers reliable, high‑quality clinical development support tailored to global sponsors operating in and entering the Japanese market.

Why CMIC CRO

CMIC CRO’s Proven Track Record

  • 30+ years

    Leading Japan's
    drug development
    as the country's first CRO

  • 1,000+

    Record of
    consulting-related
    services

  • 2,500+

    Industry experts
    deliver robust
    operational capabilities

CMIC CRO’s Edges in Entering the Japanese Market

CMIC CRO’s Edges

  • Strategic
    Consulting
    Partner

    Consulting expertise
    to develop optimal strategies

    CMIC’s consulting capabilities are underpinned not only by our deep understanding of the unique systems and practices of the Japanese market, but also by the expertise of each of our experienced specialists and the collective strength of our team. Our consultants, who possess extensive hands-on experience in pharmaceutical and medical device development, work collaboratively to identify the root causes of challenges from a multifaceted and holistic perspective, delivering fundamental solutions and optimal strategies tailored to your needs.

  • Operational
    Excellence

    A proven track record
    and execution capability as ICCC

    CMIC CRO brings extensive ICCC experience supporting global sponsors without a local presence in Japan. With hands‑on expertise gained through more than 75 ICCC projects conducted over the past five years, we deliver practical solutions that ensure reliable and efficient clinical trial execution across all development stages.

  • Therapeutic
    Expertise

    A Clinically Driven Network
    of KOLs and Sites

    CMIC CRO supports clinical development across diverse therapeutic areas through specialized teams organized by disease area. By aligning trial design and execution with disease‑specific requirements, and working closely with Japanese key opinion leaders (KOLs) and clinical sites, we enable appropriate site and investigator selection and effective patient enrollment—delivering high‑quality, efficient clinical trials tailored to each therapeutic area.

  • Group Capability

    Enabling Integrated Support
    Through Group Collaboration

    CMIC CRO leverages the broader CMIC Group’s capabilities—including SMO, CDMO, and CSO functions—to support drug development beyond the scope of a traditional CRO. By seamlessly integrating group expertise across development, manufacturing, and commercialization, we deliver stage‑appropriate solutions that enable faster decision‑making and efficient advancement of our clients’ programs.

CMIC CRO Services

CMIC CRO Services

Testimonials from Global Pharmaceutical Companies

Global pharmaceutical companies highly value CMIC’s strong presence in Japan, high operational efficiency, and reliable team performance. In multi-regional clinical trials conducted in collaboration with global CROs, CMIC has achieved seamless trial management as a “One CRO” through the alignment of infrastructure and operations.

Below are some of the comments* we have received.

Speed of site start-up and trial execution

The start-up of the clinical trial site went very smoothly, and the on-time site activation was impressive.

Everything proceeded according to plan, from site preparation to patient recruitment.

Patient recruitment and case registration

In Japan, CMIC achieved a high patient enrollment rate compared to other regions.

They played a key role in driving patient recruitment within the entire global clinical trial.

Extensive clinical trial experience and adaptability

CMIC's wealth of experience in handling a wide range of trial designs and phases gave us the confidence to entrust them with the project.

Quality and timeline management

They managed the timeline effectively, successfully balancing speed and quality.

Proactive risk management

The team was highly proactive, identifying potential issues early on and addressing them before they became problems.

These testimonials demonstrate that CMIC is recognized as a partner that combines proven execution power as a local CRO with the reliability required to support global development in clinical trials in Japan.

* The information above summarizes general trends based on feedback received by CMIC from past projects and does not include direct quotations from any specific company or individual.

Contact Us

For more information about CMIC or to discuss your needs,
click here to contact us.

Click here